Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity
- PMID: 27851899
- PMCID: PMC6455994
- DOI: 10.1016/j.neulet.2016.11.023
Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity
Abstract
Background: Neopterin is an unconjugated pteridine that is secreted in large quantities by activated macrophages and can be used as a clinical marker of activated cellular immunity and oxidative stress. We aimed to investigate whether urinary neopterin levels are associated with cognitive function in people with Down syndrome (DS).
Methods: Out of 32 adults with DS who originally participated in a longitudinal study, 25 were followed up at 4 years. Informants rated their adaptive behavior (ABAS) and the adults with DS attempted assessments of language skills and memory at both baseline and follow-up time points (Modified Memory Object Task, MOMT), and receptive vocabulary (British Picture Vocabulary Scale, BPVS).
Results: Neopterin/creatinine levels were negatively correlated with change in the MOMT total score (Spearman's Rho=-0.517, p=0.020) and change in the MOMT delayed recall score (Spearman's Rho=-0.577, p=0.008) over time, i.e. higher neopterin/creatinine level was associated with worse performance on a test of cognitive ability over time.
Conclusion: Urine neopterin may have potential as a biomarker for memory decline in Down syndrome, and could potentially also help to track progression of mild cognitive impairment (MCI) to Alzheimer's disease in other high risk populations.
Keywords: Aging; Alzheimer’s disease; Down syndrome; Memory; Neopterin; Oxidative stress.
Copyright © 2016. Published by Elsevier Ireland Ltd.
Similar articles
-
Memory decline in Down syndrome and its relationship to iPF2alpha, a urinary marker of oxidative stress.PLoS One. 2014 Jun 5;9(6):e97709. doi: 10.1371/journal.pone.0097709. eCollection 2014. PLoS One. 2014. PMID: 24901945 Free PMC article.
-
Oxidative stress and memory decline in adults with Down syndrome: longitudinal study.J Alzheimers Dis. 2012;31(2):277-83. doi: 10.3233/JAD-2012-120073. J Alzheimers Dis. 2012. PMID: 22561328
-
Sequence of cognitive decline in dementia in adults with Down's syndrome.J Intellect Disabil Res. 2000 Dec;44 ( Pt 6):654-65. doi: 10.1046/j.1365-2788.2000.00305.x. J Intellect Disabil Res. 2000. PMID: 11115020
-
Atypical aging in Down syndrome.Dev Disabil Res Rev. 2013;18(1):51-67. doi: 10.1002/ddrr.1128. Dev Disabil Res Rev. 2013. PMID: 23949829 Review.
-
Cognitive Functioning in Children with Down Syndrome: Current Knowledge and Future Directions.Adv Child Dev Behav. 2019;56:257-289. doi: 10.1016/bs.acdb.2019.01.002. Epub 2019 Feb 21. Adv Child Dev Behav. 2019. PMID: 30846049 Review.
Cited by
-
Increased Oxidative Stress as a Risk Factor in Chronic Idiopathic Axonal Polyneuropathy.J Mol Neurosci. 2018 Dec;66(4):547-551. doi: 10.1007/s12031-018-1200-5. Epub 2018 Oct 22. J Mol Neurosci. 2018. PMID: 30350254 Free PMC article.
-
Exploring peripheral fluid biomarkers for early detection of Alzheimer's disease in Down syndrome: A literature review.Heliyon. 2024 Dec 24;11(1):e41445. doi: 10.1016/j.heliyon.2024.e41445. eCollection 2025 Jan 15. Heliyon. 2024. PMID: 39850411 Free PMC article. Review.
-
Integrative Analysis Extracts a Core ceRNA Network of the Fetal Hippocampus With Down Syndrome.Front Genet. 2020 Nov 30;11:565955. doi: 10.3389/fgene.2020.565955. eCollection 2020. Front Genet. 2020. PMID: 33329702 Free PMC article.
-
Evidence of neuroinflammation and immunotherapy responsiveness in individuals with down syndrome regression disorder.J Neurodev Disord. 2022 Jun 3;14(1):35. doi: 10.1186/s11689-022-09446-w. J Neurodev Disord. 2022. PMID: 35659536 Free PMC article.
-
Acute Effects of Triathlon Race on Oxidative Stress Biomarkers.Oxid Med Cell Longev. 2020 Jan 17;2020:3062807. doi: 10.1155/2020/3062807. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32256948 Free PMC article.
References
-
- Patten DA, Germain M, Kelly MA, Slack RS. Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis. 2010;20(2):S357–S367. - PubMed
-
- Bennett S, Grant MM, Aldred S. Oxidative stress in vascular dementia and Alzheimer’s disease: A common pathology. J Alzheimers Dis. 2009;17:245–257. - PubMed
-
- Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361:1281–1289. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical